Wilke Cohen Lyme Disease Project Update & Site Visit
systemsbiology.org/news/2016/10/31/wilke-cohen-lyme-disease-project-update-site-visit/
It has been a year of milestones for the Wilke Cohen Lyme Disease Project. ISB received a transformational, multi-year pledge of $3 million from the Steven & Alexandra Cohen Foundation (read press release) and another magnanimous gift from Jeff and Liesl Wilke, who spearheaded the launch of the project in 2015. Our research team was also thrilled to be able to host Jeff and Liesl Wilke and Alex Cohen for a site visit in October. Of the research on Lyme Disease that is currently under way in the U.S., ISB’s Wilke Cohen Lyme Disease Project is one of the most prolifically funded by private philanthropy.
Photo, from left to right: Dr. Robert Moritz (ISB), Dr. Nathan Price (ISB), Jeff Wilke, Liesl Wilke, Alex Cohen, Jeanne Melino (Steven & Alexandra Cohen Foundation), Chris Addy (The Bridgespan Group)
Great to see our grantee, @ISBUSA, today & hear the latest updates on how their fighting #LymeDisease! pic.twitter.com/vW6B8AYJok
— Cohen Foundation (@cohengive) October 26, 2016
(From the press release)
Research Highlights:
- Potential biomarkers: ISB researchers have discovered potential biomarkers, including a set of proteins in the blood known to be important for bone marrow regeneration and stability and other sets of proteins that are key players in the immune response. The results are preliminary and requires extensive follow-up.
- Systems analysis of Lyme disease: ISB researchers and their collaborators have completed the first year of a prospective study in which subjects with newly diagnosed Lyme disease were enrolled and provided blood and urine specimens at several different time points. ISB’s analysis will cover blood and urine proteins, blood and urine metabolites, patients’ immune response, and genetic factors contributing to Borrelia strain differences.
- Multi-omic analysis: The new patient samples enable deep multi-omic analyses that will best reveal useful biomarkers, vaccine targets and possibly new therapeutic targets. The blood and plasma samples will help verify the previously identified protein biomarker candidates and enable detailed exploration of the patients’ immune response to Borrelia infection.
- Detection: ISB researchers have begun an in-depth mass spectrometry-based analysis of Borrelia coat proteins with the ultimate goals of developing methods for direct detection of the Borrelia pathogen and identifying potent vaccine targets.
- Proteomics: ISB’s Moritz Lab has successfully developed a way to grow large quantities of the Borrelia bacteria in the lab, which is necessary to enable the study and identification of the proteins that are crucial to developing diagnostic tools for Lyme.
Related Articles
-
ISB’s Moritz Lab Lands NIH Grant to Study Lyme Disease
ISB’s Moritz Lab has received research funding totaling nearly $525,000 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to develop “novel peptide based biomarkers for Lyme disease diagnostics.”
Read More -
ISB’s proteomics research in the spotlight
Microsoft Research recently deployed a video crew to come to ISB to speak with our researchers about proteomics and sharing peptide data. A story featuring the video was published on the Microsoft Research blog.
Read More -
Reconstructing 'Ötzi' the Iceman’s last meal
Members of the Moritz lab, as part of an international consortium centered in Bolzano Italy, reports this week in Cell, “Current Biology”, a multi-omic approach to identify the stomach contents and microbiome of the 5300 year old Mummy, Oetzi, the Iceman from the Oetzal Alps on the Austrian/Italian border.
Read More
-
Key Strategies for Implementing Proteomics-Based Tests Across Disease States Highlighted in Current Opinion in Biotechnology
ISB, Integrated Diagnostics and Sera Prognostics just announced a paper entitled, “The building blocks of successful translation of proteomics to the clinic,” by Leroy Hood and colleagues published online in Current Opinion in Biotechnology.
Read More -
The Other Malaria: Finding New Targets for a Vaccine Against Plasmodium vivax
A new report in PLOS Neglected Tropical Diseases describes the results of an international collaboration led by researchers at ISB and Seattle’s Center for Infectious Disease Research (CIDResearch). We used mass spectrometry-based proteomics to identify nearly 2,000 proteins present in Plasmodium vivax parasites, one of the Plasmodium species that cause the disease malaria in humans. The work was done on parasites dissected from mosquito salivary glands, parasites that were in…
Read More -
ISB Proteomics: Moritz Lab Hosts TPP Workshop in Delhi
A team from the Moritz Lab at ISB headed to Delhi, India, to host a workshop on the Trans-Proteomic Pipeline (TPP). @ISBUSA Luis Mendoza and Dave Campbell open up the TPP course in Delhi India today to teach proteomics from the Moritz Lab. Welcome students pic.twitter.com/01hkteGfrr — rmoritz (@r_l_moritz) December 9, 2016 Many thanks from the Moritz lab @ISBUSA to the TPP Delhi Course participants and thanks to Brijesh Pandey…
Read More
-
‘A Better Blood Test for Liver Damage’
Chemical & Engineering News highlighted ISB’s recent publication (Identifying Organ-Specific Blood Biomarkers for Acute Liver Injury) in the Journal of Proteome Research. “For many years, clinicians have relied on assays for two enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST), to detect liver injury. These biomarkers have limitations, says Leroy Hood of the Institute for Systems Biology, such as a short half-life and a tendency to underreport damage in certain…
Read More -
New Study Identifies Organ-Specific Biomarkers for Acute Liver Injury
ISB scientists recently published a study in the Journal of Proteome Research that presents results from a study on identifying organ-specific blood biomarkers for acute liver injury due to over-exposure to acetaminophen. From the summary: 3 Bullets: Finding organ-specific blood biomarkers for disease that are clinically useful is challenging. New study identifies organ-specific blood biomarkers for acute liver injury caused by over-exposure to acetaminophen. ISB researchers use the powerful, targeted…
Read More -
Wilke Cohen Lyme Disease Project Receives $3M from the Steven & Alexandra Cohen Foundation
PRESS RELEASE Total Funding Has Reached $6.1 Million ISB Researchers Have Discovered Potential Biomarkers and Successfully Reproduced the Borrelia Bacteria in the Lab SEATTLE – June 1, 2016 – Institute for Systems Biology (ISB) has received a transformational, multi-year pledge from the Steven & Alexandra Cohen Foundation to support the Wilke Cohen Lyme Disease Project. In addition to an initial $3.1 million in funding from Jeff and Liesl Wilke, Jeff…
Read More
-
Dissecting Mosquitoes is Hard!
Photo by Hsiao-Ching Chou Dr. Kristian Swearingen is a research scientist in the Moritz Lab at ISB. He and his collaborators just published a paper in PLOS Pathogens that describes potential new targets for malaria vaccines. Read his article about the research. Asked about the challenge of having to dissect thousands of mosquitoes, he commented: When we started this project, my collaborators collected all the parasites and I focused on…
Read More -
ISB Q&A: Dr. Robert Moritz on Ötzi the Iceman
Ötzi the Iceman: In a study published in the Jan. 8, 2016, issue of the journal Science, researchers from the Moritz group at ISB collaborated with a worldwide consortia headed by Prof. Albert Zink and Dr. Frank Maixner, of the Institute for Mummies and the Iceman at the European Academy of Bozen/Bolzano (EURAC) in Italy; Prof. Thomas Rattei, of the University of Vienna; and Dr. Rudi Grimm, of University of…
Read More -
The 5300-year-old Helicobacter pylori genome of the Iceman
ISB’s Moritz Group, which specializes in proteomics, collaborated on research related to study pathogens from the stomach content and microbiome of Ötzi, a glacier mummy from the European Copper Age. The results were published in Science. Read the article here. Institute for Systems Biology collaborates with researchers worldwide to study pathogens in the stomach content and microbiome of the 5300 year old European Copper Age glacier mummy “Ötzi” and discovers…
Read More
-
Dr. Robert Moritz Promoted to Professor
A message from… By Dr. Lee Hood President, Institute for Systems Biology As most of you know, Rob Moritz has recently been promoted to full professor at ISB—a promotion long overdue. As long as I have known Rob, he has always done things without fuss, but this time we will toast him for his achievement. He also wants to credit the efforts of his group for their significant contributions that…
Read More -
GiveBIG 2015
Date: Tuesday, May 5th, 2015 Time: 12:00 AM to 12:00 AM PST Where: The Seattle Foundation website Get Involved: Visit ISB’s profile page GiveBIG is an annual, community-wide day of giving hosted by The Seattle Foundation that aims to inspire regional philanthropy. Between midnight and midnight (PST) on May 5th, The Seattle Foundation and its generous sponsors will match a percentage of all contributions to local nonprofits. If you are…
Read More -
ISB Launches 3-Year Wilke Lyme Disease Project with $2.13M Funding
Study Utilizes Systems Approaches to Develop Diagnostics and Deeper Understanding of Chronic Lyme PRESS RELEASE, SEATTLE, March 26, 2015 – Institute for Systems Biology (ISB) has received $2.13 million in transformational gifts from Jeff and Liesl Wilke; Jeff and MacKenzie Bezos; and the Bay Area Lyme Foundation to tackle chronic Lyme disease, a highly complex and often misdiagnosed disease that can be debilitating for those who do not respond to…
Read More
-
ISB releases open-source software to analyze digital fingerprint of protein data
3 Bullets SWATH mass spectrometry, an emerging protein analysis technique being pioneered by ISB researchers, provides a digital fingerprint of all accessible proteins in a sample. The data generated by the SWATH technique are highly complex and require sophisticated computational tools in order to extract identities from a sea of data. ISB researchers have released a free, open source program that allows users to confidently identify and quantify proteins analyzed…
Read More -
ISB and P&G researchers identify markers of healthy skin development
3 Bullets: The barrier function of skin is integral to personal well-being and is associated with several widespread diseases such as eczema and psoriasis. ISB and Procter & Gamble researchers used human skin grown in the lab to measure changes in protein levels as the skin matures. The results of this study provide many new markers for healthy skin development. By Dr. Kristian Swearingen and Dr. Jason Winget In a…
Read More -
Researchers Find Key Protein Tied to Production of ‘Good’ Cholesterol
3 Bullets: Inflammation causes cholesterol buildup and leads to cardiovascular disease, the leading cause of death in the world ISB, Seattle Biomed, and Oregon State University researchers collaborate to identify a compendium of proteins that control expression of a key regulator of cholesterol efflux Targeting cholesterol efflux to HDL is a potentially important therapeutic strategy for preventing and treating cardiovascular disease By Dr. Mark Gillespie Cells of the immune system,…
Read More
-
Let Us Tell You Everything We Know About Proteomics – Everything
3 Bullets: Proteomics experiments generate huge amounts of raw data, most of which cannot be easily shared or described in a publication. ISB researchers curate publicly accessible databases that allow researchers to share their data with the world and to use data others have collected. All data are analyzed in a consistent manner and results are presented via searchable, user-friendly web applications. By Dr. Kristian Swearingen Institute for Systems Biology…
Read More -
A New Approach to Identifying How the Deadly Dengue Virus Multiplies
3 Bullets: Dengue virus is the most prevalent mosquito-borne virus worldwide, infecting an estimated 400 million people per year and causing about 25,000 deaths. It’s necessary to understand the molecular mechanisms of dengue replication in order to develop an effective treatment. Researchers at ISB and Seattle BioMed developed a novel approach for identifying host proteins that associate with dengue replication machinery. By Thurston Herricks Dengue virus (DENV) infects approximately 400…
Read More -
New Structural Map Helps To Understand Aggressive Tumors
3 Bullets: Aggressive tumor growth is linked to high activity of a macromolecular assembly called RNA polymerase I. ISB and FHCRC researchers collaborate to map the architecture of the assembly using a powerful crosslinking-mass spectrometry (CXMS) technology. Structural maps provide important insights into therapeutic targets for cancer treatment. By Mark Gillespie Rapidly growing tumor cells require large amounts of protein for their survival. This increased protein synthesis, or translation, can…
Read More
-
ISB’s 2013 Annual Report is Now Available
Institute for Systems Biology has a dizzying breadth of research projects. But when we talk about what we do, it’s how we do it that matters most. The systems approach that we pioneered and exemplify continues to distinguish our ability to tackle the most complex biological and environmental challenges today. Because of how we apply our hallmark collaborative, cross-disciplinary and integrative approach, our collective success is greater than the sum…
Read More -
ISB Researchers Identify New Protein Modification Critical to Growth of Tuberculosis Pathogen
3 Bullets: Institute for Systems Biology and Seattle BioMed researchers collaborated and discovered a new protein post-translational modification in the human pathogen Mycobacterium tuberculosis. Post-translational modifications are essential mechanisms used by cells to diversify protein functions and ISB scientists identified the rare phosphorylated tyrosine post translational modification on Mycobacterium tuberculosis proteins using mass spectrometry. Inhibiting phosphotyrosine modified amino acids in Mycobacterium tuberculosis severely limits the growth of this widespread deadly…
Read More -
It’s National Cancer Research Month: How To Help
May has been designated "National Cancer Research Month" and we'd like to share a little about how ISB is using the systems biology approach to tackle some of the complexities of researching cancers. You can read our four-part series on how ISB's pioneering systems biology has made an impact and continues to clear new pathways for the cancer research field. Please visit aacr.org to learn more about NCRM. Support ISB's…
Read More
-
ISB’s Robert Moritz Lab Receives NIGMS Grant for Trans Proteomic Pipeline
The National Institute Of General Medical Sciences of the NIH has awarded Principal Investigator(s): Eric Deutsch, PhD, and Robert L. Moritz, PhD, a continuing R01 grant GM087221 for the ongoing development of the Trans-Proteomic Pipeline. The award titled “Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry” will continue the work of the ISB flagship proteomics analysis suite of open-source programs that has been downloaded thousands of times…
Read More -
The Rise of Open Proteomics
Researchers at EMBL-EBI, Institute for Systems Biology and other partnering organizations have launched ProteomeXchange, a public portal for exchanging proteomics data generated from mass-spectrometry experiments and other related information. From the EMBL-EBI-issued press release: Eric Deutsch, head of PeptideAtlas at the Institute for Systems Biology in the U.S., says: “I’m certain that the ProteomeXchange system is already leading to greater awareness and reuse of publicly available datasets. I’m regularly contacted…
Read More -
ISB’s Trans Proteomic Pipeline Software in Demand
Luis Mendoza and Eric Deutsch, of the Moritz lab, were at CINVESTAV (a federal institute in Irapuato, Mexico) last week to teach a workshop on the Trans-Proteomic Pipeline software. From Luis (pictured above): "We covered the basics of data analysis of tandem mass spectrometry data using the TPP, including the justification and theory behind the methods as well as interpretation of the results via hands-on tutorials. We had a full…
Read More
-
Dr. Jeff Ranish Receives Promotion
Congratulations to Dr. Jeff Ranish on his promotion to Associate Professor. Jeff has been with ISB since its founding in 2000. Read about the Ranish lab group.
Read More -
ISB, Lee Hood on Forbes.com
John Nosta, a contributor to Forbes.com, posted this piece today and included a mention of a collaboration between Indi and ISB on a diagnostic that may help identify benign lung nodules. From Diagnosis to Treatment, Has Lung Cancer Begun To Turn The Corner? This study suggests the tremendous power of using systems biology and bioinformatics to better understand health and disease,” said Lee Hood, M.D., Ph.D., co-author of the study; co-founder…
Read More -
ISB’s 2012 Annual Report is Now Online
ISB's annual report is now available. This year, we created a web site for the report. It highlights nine headlines from 2012 and also includes a stirring piece from our president, Dr. Lee Hood, on "Inventing the Future." You can explore the site at: annualreport.systemsbiology.net/2012.
Read More
-
Big Money, Big Science
America’s most productive biologist on philanthropy’s role in science Leroy Hood, M.D., Ph.D., is one of America’s most successful and distinguished scientist-inventors. Four devices he created proved instrumental in decoding the human genome. He pioneered the important new field of systems biology, which studies complex biological linkages and uses technology and mathematics to map and explain interrelationships. He has been awarded seven of the highest prizes in experimental science, and…
Read More -
Connecting the Dots: Obama’s Plan to Map the Brain
What You Saw in the News: On Feb. 18, The New York Times published a front-page story headlined “Obama Seeking to Boost Study of Human Brain.” (Download PDF: ObamaNYTBrainMap.) While the administration has not formally announced this brain mapping project, the NYT was able to gather enough details from scientists involved in planning the project to publish a report. Participating government agencies and private foundations include the…
Read More -
ISB Innovation in Action
Above: Kristian Swearingen and the re-engineered FAIMS device. (Editor's Note: This post shows a wonderful example of the collaborative, innovative and entrepreneurial ethic that ISB nurtures. Even if the science or technology is difficult to explain concisely, the cross-disciplinary and integrative nature of how our work is done and the pioneering spirit come through. How cool is that?) By Terry Farrah What do you do when your mass spectrometer accessory…
Read More
-
I ♥ Proteins
By Terry Farrah Since I first learned about them as a college sophomore, protein molecules have been my scientific passion. I love them for the beauty of their shapes and functions. Protein molecules are central to the workings of life, but in popular culture they are the unsung hero next to their high profile cousin, DNA. Everyone knows that DNA is the blueprint for life. But does one section of…
Read More